Schedule 13G ownership disclosure
NOVELION THERAPEUTICS, INC.
Security class unavailable · CUSIP: 67001K202
Event date: 2019-09-23
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,703,420
- Percent of class
- 18.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-19-000509
- Form type
- SC 13G
- Filer
- NOVELION THERAPEUTICS INC.
- CIK
- CIK 827809
- Filed
- Oct 02, 2019
- Reporting period
- Sep 23, 2019
- Description
- Schedule 13G beneficial ownership